HAS Healthcare Advanced Synthesis

HAS Healthcare Advanced Synthesis is part of the HAS Group. Rooted in decades of Swiss precision and a robust portfolio of established APIs and pharmaceutical products, the HAS Group is a fully integrated CDMO leader. We unite complementary expertise in chemical and biological development, specializing in APIs, HPAPIs, anticancer compounds, linker-payloads, and Antibody-Drug Conjugates (ADCs). Our solutions guide projects from early-phase development through commercial supply, leveraging multiple GMP-certified sites across Switzerland. We combine scientific excellence with strategic agility to accelerate our partners' success. Whether advancing early-stage research or scaling for global markets, HAS Group is your trusted partner.